REPLIGEN ($RGEN) Releases Q3 2026 Earnings
Alpha Vantage · Quiver Quantitative · · AI-summarised by FinFlash
REPLIGEN ($RGEN) announced its Q3 2026 earnings, reporting $0.53 per share, surpassing analyst estimates, but revenue of $209.31 million missed expectations. Insider trading activity showed sales by executives, while institutional investors had mixed movements in their holdings. Analysts have issued "Overweight" ratings and a median price target of Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context